Musk, Altman, China Fight for Brain Implant Market
A global race to control a nascent $320 billion brain-implant market pits Elon Musk and Sam Altman against Chinese ri...
This article outlines scenarios where target date funds may be preferable to index funds in a 401(k), focusing on simplicity and risk management.
25,845 articlesA global race to control a nascent $320 billion brain-implant market pits Elon Musk and Sam Altman against Chinese ri...
A day of mixed signals, with Nvidia’s surge fading and tech shares pulling the Nasdaq and S&P 500 lower. Here’s what ...
A small group of foreign exporters now accounts for the overwhelming majority of shotguns imported into the United St...
Geopolitical risk in the Middle East is reshaping energy markets. Five high-yield energy stocks offer robust dividend...
A shifting geopolitical landscape intersects AI, policy, and crypto. This article breaks down what Anthropic's used I...
Shiba Inu continues its slide, dropping about 17% over the past two weeks and pushing market sentiment toward cautiou...
A surprise $3 billion Fed liquidity operation comes as oil-driven market jitters push risk assets, including Bitcoin,...
Ross Stores reports a strong spring start and lifts its annual outlook, sending shares higher as consumers flock to d...
A fresh Goldman Sachs memo warns that risk premia have fallen to crisis-era levels, signaling a potential stock marke...
March 2026 brings choppy markets and rising demand for fast, reliable screeners. This piece ranks the best stock scre...
As 2025 unfolds, MediWound faces a pivotal year for debt, cash, and milestones. This analysis breaks down what mediwo...
Markets are betting that rates will edge lower this year, nudging investors toward income-focused and rate-sensitive ...